» Articles » PMID: 28656173

Heparin Mimics Extracellular DNA in Binding to Cell Surface-Localized Proteins and Promoting Biofilm Formation

Overview
Journal mSphere
Date 2017 Jun 29
PMID 28656173
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

is a leading cause of catheter-related bloodstream infections. Biofilms form on these implants and are held together by a matrix composed of proteins, polysaccharides, and extracellular DNA (eDNA). Heparin is a sulfated glycosaminoglycan that is routinely used in central venous catheters to prevent thrombosis, but it has been shown to stimulate biofilm formation through an unknown mechanism. Data presented here reveal that heparin enhances biofilm capacity in many and coagulase-negative staphylococcal strains, and it is incorporated into the USA300 methicillin-resistant (MRSA) biofilm matrix. The . USA300 biofilms containing heparin are sensitive to proteinase K treatment, which suggests that proteins have an important structural role during heparin incorporation. Multiple heparin-binding proteins were identified by proteomics of the secreted and cell wall fractions. Proteins known to contribute to biofilm were identified, and some proteins were reported to have the ability to bind eDNA, such as the major autolysin (Atl) and the immunodominant surface protein B (IsaB). Mutants defective in IsaB showed a moderate decrease in biofilm capacity in the presence of heparin. Our findings suggested that heparin is substituting for eDNA during biofilm development. To test this model, eDNA content was increased in biofilms through inactivation of nuclease activity, and the heparin enhancement effect was attenuated. Collectively, these data support the hypothesis that can incorporate heparin into the matrix and enhance biofilm capacity by taking advantage of existing eDNA-binding proteins. and coagulase-negative staphylococci (CoNS) are the leading causes of catheter implant infections. Identifying the factors that stimulate catheter infection and the mechanism involved is important for preventing such infections. Heparin, the main component of catheter lock solutions, has been shown previously to stimulate biofilm formation through an unknown pathway. This work identifies multiple heparin-binding proteins in , and it reveals a potential mechanism through which heparin enhances biofilm capacity. Understanding the details of the heparin enhancement effect could guide future use of appropriate lock solutions for catheter implants.

Citing Articles

Biofilm formation by is triggered by a drop in the levels of a cyclic dinucleotide.

Syed A, Baral R, Van Vlack E, Gil-Marques M, Lenhart T, Hooper D Proc Natl Acad Sci U S A. 2024; 121(52):e2417323121.

PMID: 39680756 PMC: 11670122. DOI: 10.1073/pnas.2417323121.


Heparin binding proteins on monocyte cell surfaces regulates pre-inflammatory responses in diabetes.

Wang A, Wang A, Hascall V J Allergy Infect Dis. 2024; 4(1):16-23.

PMID: 38618493 PMC: 11013956. DOI: 10.46439/allergy.4.037.


DNA and histones impair the mechanical stability and lytic susceptibility of fibrin formed by staphylocoagulase.

Komorowicz E, Farkas V, Szabo L, Cherrington S, Thelwell C, Kolev K Front Immunol. 2023; 14:1233128.

PMID: 37662916 PMC: 10470048. DOI: 10.3389/fimmu.2023.1233128.


Fibrinolytic and antibiotic treatment of prosthetic vascular graft infections in a novel rat model.

Johansen M, Rahbek S, Jensen-Fangel S, Minero G, Jensen L, Larsen O PLoS One. 2023; 18(7):e0287671.

PMID: 37463137 PMC: 10353806. DOI: 10.1371/journal.pone.0287671.


Inhibition of bacterial swimming by heparin binding of flagellin FliC from Escherichia coli strain Nissle 1917.

Yang G, Yang L, Zhou X Arch Microbiol. 2023; 205(8):286.

PMID: 37452842 DOI: 10.1007/s00203-023-03622-9.


References
1.
Regassa L, Novick R, Betley M . Glucose and nonmaintained pH decrease expression of the accessory gene regulator (agr) in Staphylococcus aureus. Infect Immun. 1992; 60(8):3381-8. PMC: 257325. DOI: 10.1128/iai.60.8.3381-3388.1992. View

2.
Novick R, Ross H, Projan S, Kornblum J, Kreiswirth B, Moghazeh S . Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 1993; 12(10):3967-75. PMC: 413679. DOI: 10.1002/j.1460-2075.1993.tb06074.x. View

3.
Becker S, Frankel M, Schneewind O, Missiakas D . Release of protein A from the cell wall of Staphylococcus aureus. Proc Natl Acad Sci U S A. 2014; 111(4):1574-9. PMC: 3910568. DOI: 10.1073/pnas.1317181111. View

4.
Lister J, Horswill A . Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front Cell Infect Microbiol. 2015; 4:178. PMC: 4275032. DOI: 10.3389/fcimb.2014.00178. View

5.
Ashton D, Mehta R, Ward D, McDonald B, Aguilar M . Recent advances in continuous renal replacement therapy: citrate anticoagulated continuous arteriovenous hemodialysis. ANNA J. 1991; 18(3):263-7, 329. View